raw material

Broker's Calls

What’s next for UG Healthcare after a disappointing FY17

SINGAPORE (Sept 4): Maybank Kim Eng Research is maintaining its “sell” call on UG Healthcare Corporation with a 16% lower price target of 21 cents while noting weak cost management and a weaker ability to pass on additional costs.
×